- Home
- OCEAW vs WWW Comparison
OCEAW vs WWW Comparison
Compare OCEAW & WWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEAW
- WWW
- Stock Information
- Founded
- OCEAW N/A
- WWW 1883
- Country
- OCEAW United States
- WWW United States
- Employees
- OCEAW 7
- WWW N/A
- Industry
- OCEAW Biotechnology: Pharmaceutical Preparations
- WWW Shoe Manufacturing
- Sector
- OCEAW Health Care
- WWW Consumer Discretionary
- Exchange
- OCEAW Nasdaq
- WWW Nasdaq
- Market Cap
- OCEAW N/A
- WWW N/A
- IPO Year
- OCEAW 2021
- WWW N/A
- Fundamental
- Price
- OCEAW $0.02
- WWW $10.79
- Analyst Decision
- OCEAW
- WWW Strong Buy
- Analyst Count
- OCEAW 0
- WWW 8
- Target Price
- OCEAW N/A
- WWW $18.75
- AVG Volume (30 Days)
- OCEAW N/A
- WWW 1.7M
- Earning Date
- OCEAW N/A
- WWW 05-07-2025
- Dividend Yield
- OCEAW N/A
- WWW 3.70%
- EPS Growth
- OCEAW N/A
- WWW N/A
- EPS
- OCEAW N/A
- WWW 0.58
- Revenue
- OCEAW N/A
- WWW $1,755,000,000.00
- Revenue This Year
- OCEAW N/A
- WWW $4.50
- Revenue Next Year
- OCEAW N/A
- WWW $5.34
- P/E Ratio
- OCEAW N/A
- WWW $18.64
- Revenue Growth
- OCEAW N/A
- WWW N/A
- 52 Week Low
- OCEAW N/A
- WWW $9.36
- 52 Week High
- OCEAW N/A
- WWW $24.64
- Technical
- Relative Strength Index (RSI)
- OCEAW N/A
- WWW 37.04
- Support Level
- OCEAW N/A
- WWW $10.46
- Resistance Level
- OCEAW N/A
- WWW $11.56
- Average True Range (ATR)
- OCEAW 0.00
- WWW 1.15
- MACD
- OCEAW 0.00
- WWW -0.04
- Stochastic Oscillator
- OCEAW 0.00
- WWW 22.96
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.